It is well established that lung cancer patients harbour many driver gene mutations, such as K-ras (6, 7), EGFR (8), EML4-ALK (9), and CLIP1-LTK (10), which contribute to the initiation and progression of lung cancer. Here, EML4 is linked to lung carcinoma.